As diabetes care continues to be a significant focus, innovative treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a exciting advancement in incretin mimetic medications. While https://sites2000.com/story12039785/the-new-drug-vs-tirzepatid-vs-semaglutide-a-direct-look